HealthLeaders Media July 25, 2024
Prescription drug rebates were once a good idea. Not any more.
KEY TAKEAWAYS
– Traditionally, pharmacy benefit managers (PBMs) quietly negotiate drug prices with drug managers, including a rebate amount paid by the manufacturer to the PBM.
– Instead of lowering drug costs, these rebates now often result in the use of higher-cost drugs with higher out-of-pocket costs for members.
– The healthcare industry should move away from rebates and examine alternatives to compensating drug manufactuers.
Editor’s Note: Sandra Clarke is the EVP and Chief Operating Officer of Blue Shield of California.
What happens when you squeeze a balloon? While the air inside shifts away from where you put pressure, the total air volume is still trapped inside. Prescription drug...
Today's Sponsors
Today's Sponsor